The Longitudinal Associations of Inflammatory Biomarkers and Depression Revisited: Systematic Review, Meta-analysis, and Meta-regression

Overview

Journal Mol Psychiatry

Specialties Molecular Biology
Psychiatry

Date 2020 Aug 19

PMID 32807846

Citations 102

Authors

Naoise Mac Giollabhui

Tommy H Ng

Lauren M Ellman

Lauren B Alloy

Affiliations

Soon will be listed here.

Abstract

The innate immune system is dysregulated in depression; however, less is known about the longitudinal associations of depression and inflammatory biomarkers. We investigated the prospective associations of depression and inflammatory biomarkers [interleukin-6 (IL-6), Tumor Necrosis Factor-Alpha (TNF-α), and C-reactive protein (CRP)] in community samples, both unadjusted and adjusted for covariates. The review, registered with PROSPERO, searched for published and unpublished studies via MEDLINE/PsycINFO/PsycARTICLES/EMBASE/Proquest Dissertation. Standardized Fisher transformations of the correlation/beta coefficients, both unadjusted and adjusted for covariates, were extracted from studies examining the prospective associations of depression and inflammatory biomarkers. Systematic review conducted in January, 2019 included 38 studies representing 58,256 participants, with up to 27 studies included in random-effects meta-analysis. Higher CRP/IL-6 were associated with future depressive symptoms, and higher depressive symptoms were associated with higher future CRP/IL-6 in both unadjusted and adjusted analyses - this is the first meta-analysis reporting an adjusted association of IL-6 with future depression. The adjusted prospective associations of depression with CRP/CRP with depression were substantially attenuated and small in magnitude. No significant associations were observed for TNF-α. No conclusive results were observed in studies of clinical depression. Meta-regression indicated that the association of CRP and future depression was larger in older samples and in studies not controlling for possible infection. Small, prospective associations of depression and inflammatory biomarkers are observed in both directions, particularly for IL-6; however, the strength and importance of this relationship is likely obscured by the heterogeneity in depression and profound study/methodological differences. Implications for future studies are discussed.

Citing Articles

Loneliness and health-related quality of life in Chinese adolescents: the mediating role of depressive symptoms and the moderating role of age.

Hu W, Feng X, Cao W, Li J, Luo S, Lin L Soc Psychiatry Psychiatr Epidemiol. 2025; .

PMID: 39976711 DOI: 10.1007/s00127-025-02834-2.

Developing a translational research framework for MDD: combining biomolecular mechanisms with a spiraling risk factor model.

van Baalen M, van der Velden L, van der Gronde T, Pieters T Front Psychiatry. 2025; 15():1463929.

PMID: 39839132 PMC: 11747824. DOI: 10.3389/fpsyt.2024.1463929.

Meta analysis of resting frontal alpha asymmetry as a biomarker of depression.

Luo Y, Tang M, Fan X Npj Ment Health Res. 2025; 4(1):2.

PMID: 39820155 PMC: 11739517. DOI: 10.1038/s44184-025-00117-x.

Associations between biomarkers of inflammation and depressive symptoms-potential differences between diabetes types and symptom clusters of depression.

Herder C, Zhu A, Schmitt A, Spagnuolo M, Kulzer B, Roden M Transl Psychiatry. 2025; 15(1):9.

PMID: 39799156 PMC: 11724873. DOI: 10.1038/s41398-024-03209-y.

The impact of inflammatory response on psychological status of medical staff during COVID-19 pandemic.

Wang D, Li H, Liu Y, Li H, Liu Y, Hou L Psicol Reflex Crit. 2025; 38(1):3.

PMID: 39757257 PMC: 11700958. DOI: 10.1186/s41155-024-00335-w.

References

Erskine H, Moffitt T, Copeland W, Costello E, Ferrari A, Patton G . A heavy burden on young minds: the global burden of mental and substance use disorders in children and youth. Psychol Med. 2014; 45(7):1551-63. PMC: 5922255. DOI: 10.1017/S0033291714002888. View

Kessler R, Berglund P, Demler O, Jin R, Koretz D, Merikangas K . The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003; 289(23):3095-105. DOI: 10.1001/jama.289.23.3095. View

Burcusa S, Iacono W . Risk for recurrence in depression. Clin Psychol Rev. 2007; 27(8):959-85. PMC: 2169519. DOI: 10.1016/j.cpr.2007.02.005. View

Zimmerman M, Ellison W, Young D, Chelminski I, Dalrymple K . How many different ways do patients meet the diagnostic criteria for major depressive disorder?. Compr Psychiatry. 2014; 56:29-34. DOI: 10.1016/j.comppsych.2014.09.007. View

Olbert C, Gala G, Tupler L . Quantifying heterogeneity attributable to polythetic diagnostic criteria: theoretical framework and empirical application. J Abnorm Psychol. 2014; 123(2):452-62. DOI: 10.1037/a0036068. View

Kunugi H, Hori H, Ogawa S . Biochemical markers subtyping major depressive disorder. Psychiatry Clin Neurosci. 2015; 69(10):597-608. DOI: 10.1111/pcn.12299. View

Rush A, Trivedi M, Wisniewski S, Nierenberg A, Stewart J, Warden D . Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006; 163(11):1905-17. DOI: 10.1176/ajp.2006.163.11.1905. View

Smith R . The macrophage theory of depression. Med Hypotheses. 1991; 35(4):298-306. DOI: 10.1016/0306-9877(91)90272-z. View

Raison C, Miller A . Is depression an inflammatory disorder?. Curr Psychiatry Rep. 2011; 13(6):467-75. PMC: 3285451. DOI: 10.1007/s11920-011-0232-0. View

10.

Irwin M, Miller A . Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun. 2007; 21(4):374-83. DOI: 10.1016/j.bbi.2007.01.010. View

11.

Miller A, Maletic V, Raison C . Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009; 65(9):732-41. PMC: 2680424. DOI: 10.1016/j.biopsych.2008.11.029. View

12.

Haroon E, Raison C, Miller A . Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology. 2011; 37(1):137-62. PMC: 3238082. DOI: 10.1038/npp.2011.205. View

13.

Raison C, Capuron L, Miller A . Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2005; 27(1):24-31. PMC: 3392963. DOI: 10.1016/j.it.2005.11.006. View

14.

Dantzer R, OConnor J, Freund G, Johnson R, Kelley K . From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2007; 9(1):46-56. PMC: 2919277. DOI: 10.1038/nrn2297. View

15.

Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim E . A meta-analysis of cytokines in major depression. Biol Psychiatry. 2009; 67(5):446-57. DOI: 10.1016/j.biopsych.2009.09.033. View

16.

Howren M, Lamkin D, Suls J . Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009; 71(2):171-86. DOI: 10.1097/PSY.0b013e3181907c1b. View

17.

Udina M, Castellvi P, Moreno-Espana J, Navines R, Valdes M, Forns X . Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry. 2012; 73(8):1128-38. DOI: 10.4088/JCP.12r07694. View

18.

Musselman D, Lawson D, Gumnick J, Manatunga A, Penna S, Goodkin R . Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med. 2001; 344(13):961-6. DOI: 10.1056/NEJM200103293441303. View

19.

Schedlowski M, Engler H, Grigoleit J . Endotoxin-induced experimental systemic inflammation in humans: a model to disentangle immune-to-brain communication. Brain Behav Immun. 2014; 35:1-8. DOI: 10.1016/j.bbi.2013.09.015. View

20.

Chiu W, Su Y, Su K, Chen P . Recurrence of depressive disorders after interferon-induced depression. Transl Psychiatry. 2017; 7(2):e1026. PMC: 5438022. DOI: 10.1038/tp.2016.274. View